IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026 - 20:22
IN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The company is advancing its next-generation gamma-delta T cell engager platform and expects to release initial animal data later this year.
In its glioblastoma program, IN8bio reported data showing a roughly 97 percent improvement in progression-free survival compared to standard-of-care treatment. The company plans to present updated median overall survival data at the ASCO 2026 conference.
IN8bio will host an R&D Day on May 21, 2026 in New York City to discuss its pipeline and future directions. The company continues to develop innovative gamma-delta T cell therapies designed to target and destroy cancer cells while potentially reducing side effects associated with traditional treatments.
Financial details from the first quarter were not disclosed in the summary, but the company remains focused on advancing its clinical programs and platform technology. IN8bio is headquartered in New York and trades on the Nasdaq under the ticker INAB.
MORE NEWS
May 7, 2026 - 01:32
Pathwix AI Helps People Turn Life Goals into Financial RoadmapsDUBLIN, May 06, 2026 (GLOBE NEWSWIRE) -- As global financial markets grow more complicated by the day, Pathwix has rolled out a new approach aimed at helping everyday people connect their personal...
May 6, 2026 - 01:53
Lucid Q1 results miss estimates; cash burn expected to continue as product ramp expandsLucid Group reported first quarter financial results on Monday that fell short of analyst estimates, as the electric vehicle maker continues to navigate the costly ramp-up of its production lines....
May 5, 2026 - 10:45
$1.6B North Texas team joins financial giant Wells FargoA Frisco-based wealth management firm overseeing $1.6 billion in client assets has moved its operations to Wells Fargo Advisors. The move marks another step in the financial giant`s push to expand...
May 4, 2026 - 20:11
MSG Sports Names Paul DiCicco Executive Vice President, Chief Financial Officer and TreasurerMadison Square Garden Sports Corp. has appointed Paul DiCicco as its new Executive Vice President, Chief Financial Officer, and Treasurer. The company made the announcement on May 4, 2026, with...